Navigation Links
Professor Steven V. Ley Speaks at WuXi PharmaTech

Professor Steven V. Ley Speaks at WuXi PharmaTech -- SHANGHAI, Oct. 7 /PRNewswire-Asia/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Pharmaceuticals Click to view news release full screen  

Professor Steven V. Ley Speaks at WuXi PharmaTech

Download image

SHANGHAI, Oct. 7 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is proud to announce that Dr. Steven V. Ley, BP Professor of Chemistry at the University of Cambridge, visited WuXi AppTec facilities in Shanghai on September 28. He gave a lecture to WuXi scientists titled "New Tools for Synthesis: Enabling Technologies" as part of the WuXi AppTec Science Seminar Series.



Dr. Ley is a world-renowned organic chemist. He founded the Ley Group, which has published extensively on the synthesis of natural products and has synthesized more than 130 target compounds. Dr. Ley's work on iron chemistry, encapsulated reagents, microbial oxidation, spiroketals, and microwave chemistry has been groundbreaking. He has pioneered the use of immobilized reagents in multi-step organic synthesis to make compounds in a cleaner and more effective way. This work now incorporates flow chemistry for multistep organic synthesis applications. He has devised many practical and useful protecting groups using acetal chemistry. He has done significant work in the area of organic catalysis and was one of the inventors of tetrapropylammonium perruthenate (TPAP), a catalytic oxidant that is now used worldwide and cited extensively.

Dr. Ley has published 698 papers to date. His recent awards include the Paracelsus Prize, the Heinrich Wieland Prize, the Tetrahedron Prize, the Perkin Prize for Organic Chemistry, the High Throughput Drug Discovery Methodologies Award, the Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery and the Hans Heroff Inhoffen Medal. In 1990 he was elected to the Royal Society (London) and was President of The Royal Society of Chemistry from 2000-2002. He was named a Commander of the Order of the British Empire (CBE) in January 2002.

"It is an honor to speak at WuXi PharmaTech, which provides high-quality research and development services to the world's leading life science companies," Dr. Ley said. "I was very impressed by WuXi's comprehensive training system and the research capabilities of WuXi scientists."

"We are privileged to have Dr. Ley share his expertise with our scientists," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi AppTec. "As we broaden our R&D service scope, our success depends on the quality of our scientists. Investing in people will continue to be our key strategy."

For more information, please contact: Stephanie Liu (for the media) Tel: +86-21-5046-4362 Email: Ronald Aldridge (for investors) Tel: +1-201-585-2048 Email:

SOURCE WuXi PharmaTech
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award
2. NYU-Poly Professor Among First Winners of BioAccelerate NYC Prize; Project May Move Diagnostic Medicine from the Lab to the Palm of a Hand
3. InteKrin Therapeutics Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School
4. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
5. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
6. WellSpring Pharmaceutical, American Gastroenterological Association, and Steven Bramson of Humanscale Partner With MediaPlanet to Publish One of the Largest Digestive Wellness Campaigns in U.S. History to Overcome Upset Stomach, Nausea, IBS, and Deb
7. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
8. Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors
9. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
10. D-M-S Holdings, Inc. Announces the Filing of a Lawsuit Against Veridian Healthcare, LLC, Steven M. Bisulca and Michael Mazza
11. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
Post Your Comments:
(Date:11/26/2015)... Research and Markets ( ) has announced ... Outlook to 2019 - Rise in Cardiac Disorders and Growing ... to their offering. Boston ... scientific and others. --> The market ... Boston scientific and others. ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch can actually ... conceived of this design due to personal experience with a bad back," he said. ... and convenience, as well as increases support. It also makes it easier to eat, ...
(Date:11/28/2015)... Viejo, CA (PRWEB) , ... November 28, 2015 , ... ... new fully customizable media panels to choose from, the possibilities are endless. Users have ... and more. With the ProPanel: Pulse masking effects, users are sure to get heads ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... at the recent 2015 American Dental Association meeting in Washington D.C. revolved around the ... protect a patient’s overall health. The talk stressed the link between periodontal disease (more ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... they are handling security in light of the recent terrorist attacks in Paris, other ... to stop an attack from reaching U.S. soil. Especially around special events that may ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors ... treat it. Surviving Mesothelioma has just posted the findings on the website. Click ... analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed by ...
Breaking Medicine News(10 mins):